Scientists from CEITEC Masaryk University are collaborating with clinicians from the Department of Respiratory Diseases and TB at the University Hospital Brno (Brno, Czech Republic) to improve the diagnosis of cystic fibrosis, specifically in newborn babies. In a new study published in the Journal of Chromatography A, a new "skin wipe" sweat sampling method is presented that reduces the time required for sampling to under a minute and utilizes capillary electrophoresis (CE) to simultaneously determine chloride, sodium, and potassium ions in sweat samples.
Photo Credit: Compassionate Eye Foundation/Three Images/Getty Images
Scientists from CEITEC Masaryk University are collaborating with clinicians from the Department of Respiratory Diseases and TB at the University Hospital Brno (Brno, Czech Republic) to improve the diagnosis of cystic fibrosis, specifically in newborn babies. In a new study published in the Journal of Chromatography A, a new “skin wipe” sweat sampling method is presented that reduces the time required for sampling to under a minute and uses capillary electrophoresis (CE)to simultaneously determine chloride, sodium, and potassium ions in sweat samples.1
Cystic fibrosis (CF) is a rare genetic disorder resulting from a mutation in a transmembrane conductance regulator (CFTR) gene that causes defective ion transfer across epithelial cellular membranes, causing the formation of thicker and stickier mucus. This is a problem for those affected because it impacts multiple organs, particularly the lungs, and can result in repeated lung infections. According to the paper, there are screening programmes worldwide to detect the disorder in newborn babies because studies have shown early diagnosis can improve patient outlook.
The quickest screening method for the disorder is the “sweat test”; results of the test are subsequently confirmed by genetic testing. During the sweat test a chemical to cause sweating is applied to a small area on the arm or leg, and an electrode is then applied over the same area. A weak electrical current is applied to the area and then the sweat is collected, using, for example, filter paper or gauze. The sweat is then analyzed to determine the levels of chloride ions; elevated chloride ion levels indicate a positive result.
Corresponding author Petr Kuban told The Column: “We realized that the 30-min sampling using pilocarpine iontophoresis and sweat induction might not be the most comfortable for the very small babies. Additionally the analysis of chloride alone gives many false positive/negative results. Chloride levels also change with age and the border values for CF diagnosis are not clearly defined.” He added: “We thought that since we have the analytical technique (capillary electrophoresis coupled with contactless conductivity detection [CE-C4D]) able to analyze many ions simultaneously, it would be interesting to see if there are other correlations among the ions that could be used for more reliable screening.”
Cotton swabs soaked in water were wiped against the skin of 10 patients and 10 healthy participants three times and were then extracted in deionized water for 15 min. The extracts were then analyzed by double opposite end injection capillary electrophoresis with contactless conductomeric detection to determine chloride, sodium, and potassium ions. Kuban said: “We were analyzing breath samples of CF patients in another study and as a part of this study, we decided to take some alternative samples, such as skin wipe and saliva. We knew that we can analyze the selected ions simply by our CE-C4D instrument and by careful studying [of] the resulting electropherograms, we noticed the differences in the ion ratios of healthy volunteers and CF patients. These differences repeated rather consistently in all samples.”
A key drawback of the current “sweat test” is the frequency of false positive and false negative results when relying on the determination of chloride ions. The new method reduced this by using ion concentration ratios rather than chloride ion concentration, as well as saving time during samplecollection, according to Kuban. He said: “Last but not least is also significant decrease in the cost of sampling using our developed method (skin wipe) compared to pilocarpine iontophoresis.” According to the paper, to use the method in clinical practice requires further study, which is currently underway. — B.D.
Reference
1. P. Kubán et al., Journal of Chromatography A 1358, 293–298 (2014).
This story originally appeared in The Column. Click here to view that issue.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.